Aspiration thrombectomy prior to percutaneous coronary intervention in ST-elevation myocardial infarction: a

Regina El Dib1,2, Frederick Alan Spencer3, Erica Aranha Suzumura4

  • 1Department of Anaesthesiology, Botucatu Medical School, Unesp - Univ Estadual Paulista, São Paulo, Brazil.

Insights

Aspiration thrombectomy (AT) before primary percutaneous intervention (PCI) for ST-segment elevation MI (STEMI) may slightly reduce mortality but increases stroke risk. Due to minimal absolute differences, AT is not recommended as a routine strategy.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Technology

Background:

  • Aspiration thrombectomy (AT) prior to primary percutaneous intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) has yielded inconsistent trial results.
  • Uncertainty exists regarding the net clinical benefit of AT in STEMI patients.

Purpose of the Study:

  • To systematically evaluate the efficacy and safety of aspiration thrombectomy prior to primary PCI compared to conventional PCI in STEMI patients.
  • To synthesize evidence from randomized controlled trials (RCTs) to inform clinical practice guidelines.

Main Methods:

  • Comprehensive literature search of MEDLINE, EMBASE, and CENTRAL databases up to June 2015.
  • Inclusion of 20 RCTs involving 21,660 patients undergoing PCI for STEMI.
  • Data extraction and risk of bias assessment by independent reviewers, utilizing the GRADE approach for evidence certainty.

Main Results:

  • Moderate-certainty evidence indicated a non-significant trend towards reduced overall mortality with AT (RR 0.89).
  • No significant difference was observed in recurrent myocardial infarction (MI) or major bleeding events.
  • A statistically significant increase in stroke incidence was noted (RR 1.56), representing 3 additional strokes per 1000 patients over 6 months.

Conclusions:

  • Aspiration thrombectomy may offer a small, uncertain reduction in mortality but carries a risk of increased stroke.
  • The absolute benefits and harms are small and closely balanced, making AT not advisable as a routine strategy.
  • Further research may be needed to identify specific patient subgroups who could benefit from AT.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...